{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:30:30Z","timestamp":1779121830723,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.tcm.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:56:30Z","timestamp":1674039390000},"page":"159-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Editorial commentary: Adiposity, altered inflammatory pathways, and atrial fibrillation: Mechanistic links or an epiphenomenon?"],"prefix":"10.1016","volume":"34","author":[{"given":"Bilal","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-0136","authenticated-orcid":false,"given":"T. Jared","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tcm.2023.01.001_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.tcm.2023.01.001_bib0002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.tcm.2023.01.001_bib0003","unstructured":"World Health Organization. WH. Obesity and overweight 2021 [cited Accessed: 1\/6\/2023]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.tcm.2023.01.001_bib0004","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","author":"Elliott","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2023.01.001_bib0005","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.hrthm.2019.01.024","volume":"16","author":"Writing Group","year":"2019","journal-title":"Heart Rhythm."},{"issue":"14","key":"10.1016\/j.tcm.2023.01.001_bib0006","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2023.01.001_bib0007","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCEP.113.001281","article-title":"Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: con","volume":"7","author":"Hanley","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"19","key":"10.1016\/j.tcm.2023.01.001_bib0008","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2023.01.001_bib0009","article-title":"Circulating adipose tissue proteins involved in atrial fibrillation: an explorative scoping review","author":"Meulendijks","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.tcm.2023.01.001_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacep.2015.04.014","article-title":"Inflammation as a mediator of the association between race and atrial fibrillation: results from the health, aging, and body composition study","volume":"1","author":"Dewland","year":"2015","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:03:21Z","timestamp":1760936601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173823000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1050173823000038"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2023.01.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial commentary: Adiposity, altered inflammatory pathways, and atrial fibrillation: Mechanistic links or an epiphenomenon?","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2022.12.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}